Celldex Therapeutics reported $47K in Ordinary Share Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Amgen AMGN:US $ 31989M 112M
Applied Genetic Technologies AGTC:US $ 0.04M 0M
Aptinyx Inc APTX:US $ 677K 0
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Biocept BIOC:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Celldex Therapeutics CLDX:US $ 0.05M 0.01M
Cytrx CYTR:US 38.78K 2K
Glaxosmithkline GSK:US $ 1347M 0M
Merrimack Pharmaceuticals MACK:US $ 1.33M 0
Nektar Therapeutics NKTR:US $ 0.02M 0M
Newlink Genetics NLNK:US $ 0.08M 0M
Northwest Biotherapeutics NWBO:US 892K 35K
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Seattle Genetics SGEN:US $ 0.18M 0M